Combination immunotherapy with OK-432, recombinant granulocyte-colony-stimulating factor and recombinant interleukin-2 for human hepatocellular carcinoma
1996 ◽
Vol 42
(2)
◽
pp. 127-131
◽
2000 ◽
Vol 28
(3)
◽
pp. 352
◽
2010 ◽
Vol 25
(3)
◽
pp. 476
◽
1993 ◽
Vol 83
(1)
◽
pp. 7-13
◽
2016 ◽
Vol 7
(5)
◽
pp. 380
◽
2000 ◽
Vol 28
(1)
◽
pp. 96-103
◽
1999 ◽
Vol 34
(5)
◽
pp. 640-644
◽